Back to PRIMECAP MANAGEMENT CO/CA/ PRIMECAP MANAGEMENT CO/CA/

IMNMIMNM
Showing 8 of 10 quarters

Position history for PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/'s holdings in IMMUNOME INC

Yes. Primecap holds 4,581,431 shares of IMNM (Immunome), worth $97.1M, as of its Q2 2026 13F filing. It reduced the position by 206,800 shares (-4.3%) from Q1 2026. Primecap has held IMNM since Q1 2024, across 10 quarterly 13F filings. IMNM is 0.1% of Primecap's reported 13F portfolio.

Current Value

$97.1M

Current Shares

4.6M

Total Value Change

+$93M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.6M
-4.3%
$97.1M0.1%$21.19
0
2026-Q1
Increased
4.8M
+2.2%
$104.7M0.1%$21.87
31
2025-Q4
Increased
4.7M
+55.3%
$100.6M0.1%$21.48
42
2025-Q3
Decreased
3M
-0.1%
$35.3M0.0%$11.71
0
2025-Q2
Decreased
3M
-11.5%
$28.1M0.0%$9.30
0
2025-Q1
Increased
3.4M
+1115.7%
$23M0.0%$6.73
46
2024-Q4
Unchanged
280,800
0.0%
$3M0.0%$10.62
0
2024-Q3
Increased
280,800
+4.5%
$4.1M0.0%$14.62
28

Other major holders of IMNM: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used